201 related articles for article (PubMed ID: 21900597)
1. The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness.
Sun T; Oh WK; Jacobus S; Regan M; Pomerantz M; Freedman ML; Lee GS; Kantoff PW
Cancer Prev Res (Phila); 2011 Dec; 4(12):2044-50. PubMed ID: 21900597
[TBL] [Abstract][Full Text] [Related]
2. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
[TBL] [Abstract][Full Text] [Related]
4. Steroidogenic germline polymorphism predictors of prostate cancer progression in the estradiol pathway.
Lévesque E; Laverdière I; Audet-Walsh E; Caron P; Rouleau M; Fradet Y; Lacombe L; Guillemette C
Clin Cancer Res; 2014 Jun; 20(11):2971-83. PubMed ID: 24682418
[TBL] [Abstract][Full Text] [Related]
5. Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin.
Chu LW; Meyer TE; Li Q; Menashe I; Yu K; Rosenberg PS; Huang WY; Quraishi SM; Kaaks R; Weiss JM; Hayes RB; Chanock SJ; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1848-54. PubMed ID: 20551303
[TBL] [Abstract][Full Text] [Related]
6. No association of serum gonadal or pituitary hormones with prognostic parameters in stages T1 to T3 PN0M0 prostate cancer.
Fodstad P; Bjøro T; Torlakovic G; Fossa SD
J Urol; 2002 Sep; 168(3):1188-92. PubMed ID: 12187265
[TBL] [Abstract][Full Text] [Related]
7. Circulating steroid hormones and the risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
Dunning AM; Dowsett M; Healey CS; Tee L; Luben RN; Folkerd E; Novik KL; Kelemen L; Ogata S; Pharoah PD; Easton DF; Day NE; Ponder BA
J Natl Cancer Inst; 2004 Jun; 96(12):936-45. PubMed ID: 15199113
[TBL] [Abstract][Full Text] [Related]
9. Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Tsilidis KK; Travis RC; Appleby PN; Allen NE; Lindstrom S; Schumacher FR; Cox D; Hsing AW; Ma J; Severi G; Albanes D; Virtamo J; Boeing H; Bueno-de-Mesquita HB; Johansson M; Quirós JR; Riboli E; Siddiq A; Tjønneland A; Trichopoulos D; Tumino R; Gaziano JM; Giovannucci E; Hunter DJ; Kraft P; Stampfer MJ; Giles GG; Andriole GL; Berndt SI; Chanock SJ; Hayes RB; Key TJ
Am J Epidemiol; 2012 May; 175(9):926-35. PubMed ID: 22459122
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
[TBL] [Abstract][Full Text] [Related]
11. CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
Travis RC; Schumacher F; Hirschhorn JN; Kraft P; Allen NE; Albanes D; Berglund G; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Calle EE; Chanock S; Dunning AM; Hayes R; Feigelson HS; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Kaaks R; Kolonel LN; Ma J; Rodriguez L; Riboli E; Stampfer M; Stram DO; Thun MJ; Tjønneland A; Trichopoulos D; Vineis P; Virtamo J; Le Marchand L; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2734-44. PubMed ID: 19789370
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.
Canzian F; Cox DG; Setiawan VW; Stram DO; Ziegler RG; Dossus L; Beckmann L; Blanché H; Barricarte A; Berg CD; Bingham S; Buring J; Buys SS; Calle EE; Chanock SJ; Clavel-Chapelon F; DeLancey JO; Diver WR; Dorronsoro M; Haiman CA; Hallmans G; Hankinson SE; Hunter DJ; Hüsing A; Isaacs C; Khaw KT; Kolonel LN; Kraft P; Le Marchand L; Lund E; Overvad K; Panico S; Peeters PH; Pollak M; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Yeager M; Hoover RN; Riboli E; Thomas G; Henderson BE; Kaaks R; Feigelson HS
Hum Mol Genet; 2010 Oct; 19(19):3873-84. PubMed ID: 20634197
[TBL] [Abstract][Full Text] [Related]
13. Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
Price DK; Chau CH; Till C; Goodman PJ; Leach RJ; Johnson-Pais TL; Hsing AW; Hoque A; Parnes HL; Schenk JM; Tangen CM; Thompson IM; Reichardt JK; Figg WD
Cancer; 2016 Aug; 122(15):2332-40. PubMed ID: 27164191
[TBL] [Abstract][Full Text] [Related]
14. Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy.
Sun T; Lee GS; Werner L; Pomerantz M; Oh WK; Kantoff PW; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1871-8. PubMed ID: 20615892
[TBL] [Abstract][Full Text] [Related]
15. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review.
Olson SH; Bandera EV; Orlow I
Am J Epidemiol; 2007 Feb; 165(3):235-45. PubMed ID: 17110639
[TBL] [Abstract][Full Text] [Related]
16. A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Lindström S; Ma J; Altshuler D; Giovannucci E; Riboli E; Albanes D; Allen NE; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Chanock SJ; Dunning AM; Feigelson HS; Gaziano JM; Haiman CA; Hayes RB; Henderson BE; Hunter DJ; Kaaks R; Kolonel LN; Le Marchand L; Martínez C; Overvad K; Siddiq A; Stampfer M; Stattin P; Stram DO; Thun MJ; Trichopoulos D; Tumino R; Virtamo J; Weinstein SJ; Yeager M; Kraft P; Freedman ML
J Clin Endocrinol Metab; 2010 Sep; 95(9):E121-7. PubMed ID: 20534771
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer.
Cunningham JM; Hebbring SJ; McDonnell SK; Cicek MS; Christensen GB; Wang L; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):969-78. PubMed ID: 17507624
[TBL] [Abstract][Full Text] [Related]
18. Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression.
Lévesque É; Huang SP; Audet-Walsh É; Lacombe L; Bao BY; Fradet Y; Laverdière I; Rouleau M; Huang CY; Yu CC; Caron P; Guillemette C
Clin Cancer Res; 2013 Feb; 19(3):699-709. PubMed ID: 23186779
[TBL] [Abstract][Full Text] [Related]
19. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
20. The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study.
Meyer TE; Chu LW; Li Q; Yu K; Rosenberg PS; Menashe I; Chokkalingam AP; Quraishi SM; Huang WY; Weiss JM; Kaaks R; Hayes RB; Chanock SJ; Hsing AW
Prostate; 2012 Jan; 72(1):65-71. PubMed ID: 21520164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
